NowVertical Group Inc
XTSX:NOW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NowVertical Group Inc
XTSX:NOW
|
CA |
|
Applied Biosciences Corp
OTC:APPB
|
US |
|
T
|
Teco 2030 ASA
OSE:TECO
|
NO |
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
Auto Italia Holdings Ltd
HKEX:720
|
HK |
|
N
|
Neo Corporate PCL
SET:NEO
|
TH |
|
Exor NV
F:EYX
|
NL |
|
W
|
Winnergy Medical PCL
SET:WINMED
|
TH |
|
Axis Technologies Group Inc
OTC:AXTG
|
US |
|
Spruce Biosciences Inc
OTC:SPRB
|
US |
Wall St Price Targets
NOW Price Targets Summary
NowVertical Group Inc
According to Wall Street analysts, the average 1-year price target for
NOW is 0.306 CAD with a low forecast of 0.303 CAD and a high forecast of 0.315 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOW's stock price target?
Price Target
0.306
CAD
According to Wall Street analysts, the average 1-year price target for
NOW is 0.306 CAD with a low forecast of 0.303 CAD and a high forecast of 0.315 CAD.
What is the Revenue forecast for NowVertical Group Inc?
Projected CAGR
10%
Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for NowVertical Group Inc?
Projected CAGR
85%
The compound annual growth rate for Operating Income over the next 2 years is 85%.